Organoids as translational models in neuroregeneration after central nervous system injury
References
- Guan B, Anderson DB, Chen L, Feng S, Zhou H. Global, regional and national burden of traumatic brain injury and spinal cord injury, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. BMJ Open. 2023;13(10):e075049; DOI:10.1136/BMJOPEN-2023-075049.
- Papageorgiou NA, Papageorgiou P, Kotroni A, Vasiliadis E. A Comprehensive review of the importance of the main comorbidities in developing cognitive disorders in patients with spinal cord injuries. Cureus. 2024;16(9):e70071; DOI:10.7759/CUREUS.70071.
- Badhiwala JH, Wilson JR, Fehlings MG. Global burden of traumatic brain and spinal cord injury. Lancet Neurol. 2019; 18(1):24-5; DOI:10.1016/S1474-4422(18)30444-7.
- Alcántar-Garibay OV, Incontri-Abraham D, Ibarra A. Spinal cord injury-induced cognitive impairment: a narrative review. Neural Regen Res. 2022;17(12):2649-54; DOI:10.4103/1673-5374.339475.
- Li Y, Cao T, Ritzel RM, He J, Faden AI, Wu J. Dementia, depression, and associated brain inflammatory mechanisms after spinal cord injury. Cells. 2020;9(6):1420; DOI:10.3390/CELLS9061420.
- Valecillos ADV, Gater DR, Alvarez G. Concomitant brain injury and spinal cord injury management strategies: a narrative review. J Pers Med. 2022;12(7):1108; DOI:10.3390/JPM12071108.
- Ahuja CS, Wilson JR, Nori S, Kotter MRN, Druschel C, Curt A, Fehlings MG. Traumatic spinal cord injury. Nat Rev Dis Primers. 2017;3:17018; DOI:10.1038/NRDP.2017.18.
- Huang R, Gao F, Yu L, Chen H, Zhu R. Generation of neural organoids and their application in disease modeling and regenerative Medicine. Adv Sci (Weinh). 2025;12(29):e01198; DOI:10.1002/ADVS.202501198.
- Kim MS, Kim DH, Kang HK, Kook MG, Choi SW, Kang KS. Modeling of hypoxic brain injury through 3D human neural organoids. Cells. 2021;10(2):234; DOI:10.3390/CELLS10020234.
- Yu B, Zhou D, Wang F, Chen X, Li M, Su J. Organoids for tissue repair and regeneration. Mater Today Bio. 2025;33:102013; DOI:10.1016/J. MTBIO.2025.102013.
- Bertacchi M, Maharaux G, Studer M. A Hybrid 2D/3D Approach for neural differentiation into telencephalic organoids and efficient modulation of FGF8 signaling. Bio Protoc. 2025;15(12):e5354; DOI:10.21769/BIOPROTOC.5354.
- Bertacchi M, Maharaux G, Loubat A, Jung M, Studer M. FGF8-mediated gene regulation affects regional identity in human cerebral organoids. Elife. 2024;13:e98096; DOI:10.7554/ELIFE.98096.
- Solana-Manrique C, Sánchez-Pérez AM, Paricio N, Muñoz-Descalzo S. Two- and three-dimensional in vitro models of Parkinson’s and Alzheimer’s diseases: state-of-the-art and applications. Int J Mol Sci. 2025;26(2):620; DOI:10.3390/IJMS26020620.
- Logan S, Arzua T, Canfield SG, Seminary ER, Sison SL, Ebert AD, Bai X. Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models. Compr Physiol. 2019;9(2):565-611; DOI:10.1002/CPHY. C180025.
- Ma C, Seong H, Li X, Yu X, Xu S, Li Y. Human brain organoid: a versatile tool for modeling neurodegeneration diseases and for drug screening. Stem Cells Int. 2022;2022:2150680; DOI:10.1155/2022/2150680.
- Jalink P, Caiazzo M. Brain organoids: filling the need for a human model of neurological disorder. Biology (Basel). 2021;10(8):740; DOI:10.3390/BIOLOGY10080740.
- Neziri S, Köseoğlu AE, Deniz Köseoğlu G, Özgültekin B, Özgentürk NÖ. Animal models in neuroscience with alternative approaches: evolutionary, biomedical, and ethical perspectives. Animal Model Exp Med. 80-868:)6(7;2024; DOI:10.1002/AME2.12487.
- Chew L, Añonuevo A, Knock E. Generating cerebral organoids from human pluripotent stem cells. Methods Mol Biol. 2022;2389:177-99; DOI:10.1007/978-1-0716-1783-0_15.
- Fedorchak NJ, Iyer N, Ashton RS. Bioengineering tissue morphogenesis and function in human neural organoids. Semin Cell Dev Biol. 2021;111:52-9; DOI:10.1016/J.SEMCDB.2020.05.025.
- Hu D, Cao Y, Cai C, Wang G, Zhou M, Peng L, Fan Y, Lai Q, Gao Z. Establishment of human cerebral organoid systems to model early neural development and assess the central neurotoxicity of environmental toxins. Neural Regen Res. 2025;20(1):242-52; DOI:10.4103/NRR. NRR-D-23-00928.
- Lancaster MA, Knoblich JA. Organogenesis in a dish: modeling development and disease using organoid technologies. Science. 2014;345(6194):1247125; DOI:10.1126/SCIENCE.1247125.
- Tang C, Wang X, Gentleman E, Kurniawan NA. Production of neuroepithelial organoids from human-induced pluripotent stem cells for mimicking early neural tube development. Methods Mol Biol. 2025;2951:111-23; DOI:10.1007/7651_2024_546.
- Fitzgerald MQ, Chu T, Puppo F, Blanch R, Chillón M, Subramaniam S, Muotri AR. Generation of ‘semi-guided’ cortical organoids with complex neural oscillations. Nat Protoc. 2024;19(9):2712-2738; DOI:10.1038/S41596-024-00994-0.
- Estridge RC, O’Neill JE, Keung AJ. Matrigel tunes H9 stem cell-derived human cerebral organoid development. Organoids. 2023;2(4):165-76; DOI:10.3390/ORGANOIDS2040013.
- Cassel de Camps C, Aslani S, Stylianesis N, Nami H, Mohamed NV, Durcan TM, Moraes C. Hydrogel mechanics influence the growth and development of embedded brain organoids. ACS Appl Bio Mater. 2022;5(1):214-24; DOI:10.1021/ACSABM.1C01047.
- Qian X, Jacob F, Song MM, Nguyen HN, Song H, Ming GL. Generation of human brain region-specific organoids using a miniaturized spinning bioreactor. Nat Protoc. 2018;13(3):565-80; DOI:10.1038/NPROT.2017.152.
- Silva TP, Sousa-Luís R, Fernandes TG, Bekman EP, Rodrigues CAV, Vaz SH, Moreira LM, Hashimura Y, Jung S, Lee B, Carmo-Fonseca M, Cabral JMS. Transcriptome profiling of human pluripotent stem cell-derived cerebellar organoids reveals faster commitment under dynamic conditions. Biotechnol Bioeng. 2021;118(7):2781-2803; DOI:10.1002/BIT.27797.
- Gopalakrishnan J. The emergence of stem cell-based brain organoids: trends and challenges. Bioessays. 2019;41(8):e1900011; DOI:10.1002/BIES.201900011.
- Ajongbolo AO, Langhans SA. Brain organoids and assembloids-from disease modeling to drug discovery. Cells. 2025;14(11):842; DOI:10.3390/CELLS14110842.
- Hongxi W, Ruting W, Yiyang L, Qinglian H, Jibing C, Feng J. Human brain organoids: development and applications. J Microbiol Biotechnol. 2025;35:e2411040; DOI:10.4014/JMB.2411.11040.
- Nowakowski TJ, Salama SR. Cerebral organoids as an experimental platform for human neurogenomics. Cells. 2022;11(18):2803; DOI:10.3390/CELLS11182803.
- Coronel R, González-Sastre R, Mateos-Martínez P, Maeso L, Llorente-Beneyto E, Martín-Benito S, Gagosian VSC, Foti L, González-Caballero MC, López-Alonso V, Liste I. Human cerebral organoids: Complex, versatile, and human-relevant models of neural development and brain diseases. Neural Regen Res. 2026;21(3):837-54; DOI:10.4103/NRR. NRR-D-24-01639.
- Chan WK, Fetit R, Griffiths R, Marshall H, Mason JO, Price DJ. Using organoids to study human brain development and evolution. Dev Neurobiol. 2021;81(5):608-22; DOI:10.1002/DNEU.22819.
- Zhou G, Pang S, Li Y, Gao J. Progress in the generation of spinal cord organoids over the past decade and future perspectives. Neural Regen Res. 2024;19(5):1013-9; DOI:10.4103/1673-5374.385280.
- Huang R, Zhu Y, Chen H, Yu L, Liu Z, Liu Y, Wang Z, He X, Yang L, Xu X, Bai Y, Chen B, Zhu R. Progress in spinal cord organoid research: advancing understanding of neural development, disease modelling, and regenerative medicine. Biomater Transl. 2024;5(4):355-371; DOI:10.12336/BIOMATERTRANSL.2024.04.003.
- Andersen J, Revah O, Miura Y, Thom N, Amin ND, Kelley KW, Singh M, Chen X, Thete MV, Walczak EM, Vogel H, Fan HC, Paşca SP. Generation of functional human 3D cortico-motor assembloids. Cell. 2020;183(7):1913-29.e26; DOI:10.1016/J.CELL.2020.11.017.
- Kalpana K, Rao C, Semrau S, Zhang B, Noggle S, Fossati V. Generating neuroimmune assembloids using human induced pluripotent stem cell (iPSC)-derived cortical organoids and microglia. Methods Mol Biol. 2025;2951:139-58; DOI:10.1007/7651_2024_554.
- Kim SH, Chang MY. Application of human brain organoids-opportunities and challenges in modeling human brain development and neurodevelopmental diseases. Int J Mol Sci. 2023;24(15):12528; DOI:10.3390/IJMS241512528.
- Iwasa N, Matsui TK, Iguchi N, Kinugawa K, Morikawa N, Sakaguchi YM, Shiota T, Kobashigawa S, Nakanishi M, Matsubayashi M, Nagata R, Kikuchi S, Tanaka T, Eura N, Kiriyama T, Izumi T, Saito K, Kataoka H, Saito Y, Kimura W, Wanaka A, Nishimura Y, Mori E, Sugie K. Gene expression profiles of human cerebral organoids identify PPAR pathway and PKM2 as key markers for oxygen-glucose deprivation and reoxygenation. Front Cell Neurosci. 2021;15:605030; DOI:10.3389/FNCEL.2021.605030.
- Wang SN, Wang Z, Wang XY, Zhang XP, Xu TY, Miao CY. Humanized cerebral organoids-based ischemic stroke model for discovering of potential anti-stroke agents. Acta Pharmacol Sin. 2023;44(3):513-23; DOI:10.1038/S41401-022-00986-4.
- Wang SN, Wang Z, Xu TY, Cheng MH, Li WL, Miao CY. Cerebral organoids repair ischemic stroke brain injury. Transl Stroke Res. 2020;11(5):983-1000; DOI:10.1007/S12975-019-00773-0.
- Shoemaker AR, Jones IE, Jeffris KD, Gabrielli G, Togliatti AG, Pichika R, Martin E, Kiskinis E, Franz CK, Finan JD. Biofidelic dynamic compression of human cortical spheroids reproduces neurotrauma phenotypes. Dis Model Mech. 2021;14(12):dmm048916; DOI:10.1242/DMM.048916.
- Ramirez S, Mukherjee A, Sepulveda SE, Gherardelli C, Becerra-Calixto A, Bravo-Vasquez N, Soto C. Protocol for controlled cortical impact in human cerebral organoids to model traumatic brain injury. STAR Protoc. 2021;2(4):100987; DOI:10.1016/J.XPRO.2021.100987.
- Ramirez S, Mukherjee A, Sepulveda S, Becerra-Calixto A, Bravo-Vasquez N, Gherardelli C, Chavez M, Soto C. Modeling traumatic brain injury in human cerebral organoids. Cells. 2021;10(10):2683; DOI:10.3390/CELLS10102683.
- Beltrán SM, Bobo J, Habib A, Kodavali CV, Edwards L, Mamindla P, Taylor RE, LeDuc PR, Zinn PO. Characterization of neural mechanotransduction response in human traumatic brain injury organoid model. Sci Rep. 2023;13(1):13536; DOI:10.1038/S41598-023-40431-Y.
- Lai JD, Berlind JE, Fricklas G, Lie C, Urenda JP, Lam K, Sta Maria N, Jacobs R, Yu V, Zhao Z, Ichida JK. KCNJ2 inhibition mitigates mechanical injury in a human brain organoid model of traumatic brain injury. Cell Stem Cell. 2024;31(4):519-536.e8; DOI:10.1016/J.STEM.2024.03.004.
- Sirtori R, Pandey A, Shukla A, Fallini C. A tabletop blast device for the study of the long-term consequences of traumatic brain injury on brain organoids. Cell Rep Methods. 2025;5(11):101213; DOI:10.1016/J. CRMETH.2025.101213.
- Bar-Kochba E, Carneal CM, Alphonse VD, Timm AC, Ernlund AW, Rodriguez CL, Morales Pantoja IE, Smirnova L, Hartung T, Merkle AC. Advancing next-generation brain organoid platforms for investigating traumatic brain injury from repeated blast exposures. Front Bioeng Biotechnol. 2025;13:1553609; DOI:10.3389/FBIOE.2025.1553609.
- Fesharaki-Zadeh A. Oxidative stress in traumatic brain injury. Int J Mol Sci. 2022;23(21):13000; DOI:10.3390/IJMS232113000.
- Ji X, Zhou S, Wang N, Wang J, Wu Y, Duan Y, Ni P, Zhang J, Yu S. Cerebral-organoid-derived exosomes alleviate oxidative stress and promote LMX1A-dependent dopaminergic differentiation. Int J Mol Sci. 2023;24(13):11048; DOI:10.3390/IJMS241311048.
- Bao Z, Fang K, Miao Z, Li C, Yang C, Yu Q, Zhang C, Miao Z, Liu Y, Ji J. Human cerebral organoid implantation alleviated the neurological deficits of traumatic brain injury in mice. Oxid Med Cell Longev. 2021;2021:6338722; DOI:10.1155/2021/6338722.
- Bellotti C, Samudyata S, Thams S, Sellgren CM, Rostami E. Organoids and chimeras: the hopeful fusion transforming traumatic brain injury research. Acta Neuropathol Commun. 2024;12(1):141; DOI:10.1186/S40478-024-01845-5.
- Raja WK, Mungenast AE, Lin YT, Ko T, Abdurrob F, Seo J, Tsai LH. Self-organizing 3D human neural tissue derived from induced pluripotent stem cells recapitulate Alzheimer’s disease phenotypes. PLoS One. 2016;11(9):e0161969; DOI:10.1371/JOURNAL.PONE.0161969.
- Choe MS, Yeo HC, Kim JS, Lee J, Lee HJ, Kim HR, Baek KM, Jung NY, Choi M, Lee MY. Simple modeling of familial Alzheimer’s disease using human pluripotent stem cell-derived cerebral organoid technology. Stem Cell Res Ther. 2024;15(1):118; DOI:10.1186/S13287-024-03732-1.
- Ji Y, Chen X, Wang Z, Meek CJ, McLean JL, Yang Y, Yuan C, Rochet JC, Liu F, Xu R. Alzheimer’s disease patient brain extracts induce multiple pathologies in novel vascularized neuroimmune organoids for disease modeling and drug discovery. Mol Psychiatry. 2025;30(10):4558-75; DOI:10.1038/S41380-025-03041-W.
- Chen X, Sun G, Tian E, Zhang M, Davtyan H, Beach TG, Reiman EM, Blurton-Jones M, Holtzman DM, Shi Y. Modeling sporadic Alzheimer’s disease in human brain organoids under serum exposure. Adv Sci (Weinh). 2021;8(18):e2101462; DOI:10.1002/ADVS.202101462.
- Giorgi C, Castelli V, d’Angelo M, Cimini A. Organoids modeling stroke in a Petri dish. Biomedicines. 2024;12(4):877; DOI:10.3390/BIOMEDICINES12040877.
- Ideno H, Imaizumi K, Shimada H, Sanosaka T, Nemoto A, Kohyama J, Okano H. Human PSCs determine the competency of cerebral organoid differentiation via FGF signaling and epigenetic mechanisms. iScience. 2022;25(10):105140; DOI:10.1016/J.ISCI.2022.105140.
- Hong Y, Dong X, Chang L, Xie C, Chang M, Aguilar JS, Lin J, Lin J, Li QQ. Microglia-containing cerebral organoids derived from induced pluripotent stem cells for the study of neurological diseases. iScience. 2023;26(3):106267; DOI:10.1016/J.ISCI.2023.106267.
- Watanabe M, Buth JE, Haney JR, Vishlaghi N, Turcios F, Elahi LS, Gu W, Pearson CA, Kurdian A, Baliaouri NV, Collier AJ, Miranda OA, Dunn N, Chen D, Sabri S, Torre-Ubieta L, Clark AT, Plath K, Christofk HR, Kornblum HI, Gandal MJ, Novitch BG. TGFβ superfamily signaling regulates the state of human stem cell pluripotency and capacity to create well-structured telencephalic organoids. Stem Cell Reports. 2022;17(10):2220-38; DOI:10.1016/J.STEMCR.2022.08.013.
- Susaimanickam PJ, Kiral FR, Park IH. Region specific brain organoids to study neurodevelopmental disorders. Int J Stem Cells. 2022;15(1):26-40; DOI:10.15283/IJSC22006.
- Notaras M, Lodhi A, Dündar F, Collier P, Sayles NM, Tilgner H, Greening D, Colak D. Schizophrenia is defined by cell-specific neuropathology and multiple neurodevelopmental mechanisms in patient-derived cerebral organoids. Mol Psychiatry. 2022;27(3):1416-34; DOI:10.1038/S41380-021-01316-6.
- Kaiser VM, Gonzalez-Cordero A. Organoids – the future of pre-clinical development of AAV gene therapy for CNS disorders. Gene Ther. 2025; DOI:10.1038/S41434-025-00527-8.
- Depla JA, Sogorb-Gonzalez M, Mulder LA, Heine VM, Konstantinova P, van Deventer SJ, Wolthers KC, Pajkrt D, Sridhar A, Evers MM. Cerebral organoids: a human model for AAV capsid selection and therapeutic transgene efficacy in the brain. Mol Ther Methods Clin Dev. 2020;18:167-75; DOI:10.1016/J.OMTM.2020.05.028.
- Drouyer M, Merjane J, Nedelkoska T, Westhaus A, Scott S, Lee S, Burke PGR, McMullan S, Lanciego JL, Vicente AF, Bugallo R, Unzu C, González-Aseguinolaza G, Gonzalez-Cordero A, Lisowski L. Enhanced AAV transduction across preclinical CNS models: a comparative study in human brain organoids with cross-species evaluations. Mol Ther Nucleic Acids. 2024;35(3):102264; DOI:10.1016/J.OMTN.2024.102264.
- Ramamurthy RM, Atala A, Porada CD, Almeida-Porada G. Organoids and microphysiological systems: Promising models for accelerating AAV gene therapy studies. Front Immunol. 2022;13: 1011143; DOI:10.3389/FIMMU.2022.1011143.
- Latour YL, Yoon R, Thomas SE, Grant C, Li C, Sena-Esteves M, Allende ML, Proia RL, Tifft CJ. Human GLB1 knockout cerebral organoids: A model system for testing AAV9-mediated GLB1 gene therapy for reducing GM1 ganglioside storage in GM1 gangliosidosis. Mol Genet Metab Rep. 2019;21:100513; DOI:10.1016/J.YMGMR.2019.100513.
- García-Delgado AB, Campos-Cuerva R, Rosell-Valle C, Martin-López M, Casado C, Ferrari D, Márquez-Rivas J, Sánchez-Pernaute R, Fernández-Muñoz B. Brain organoids to evaluate cellular therapies. Animals (Basel). 2022;12(22):3150; DOI:10.3390/ANI12223150.
- Xue J, Chu Y, Huang Y, Chen M, Sun M, Fan Z, Wu Y, Chen L. A tumorigenicity evaluation platform for cell therapies based on brain organoids. Transl Neurodegener. 2024;13(1):53; DOI:10.1186/S40035-024-00446-5.
- Xu H, Jiao Y, Qin S, Zhao W, Chu Q, Wu K. Organoid technology in disease modelling, drug development, personalized treatment and regeneration medicine. Exp Hematol Oncol. 2018;7:30; DOI:10.1186/S40164-018-0122-9.
- Liu L, Yu L, Li Z, Li W, Huang WR. Patient-derived organoid (PDO) platforms to facilitate clinical decision making. J Transl Med. 2021; 19(1):40; DOI:10.1186/S12967-020-02677-2.
- Kondo J, Inoue M. Application of cancer organoid model for drug screening and personalized therapy. Cells. 2019; 8(5):470; DOI:10.3390/CELLS8050470.
- Piraino F, Costa M, Meyer M, Cornish G, Ceroni C, Garnier V, Hoehnel-Ka S, Brandenberg N. Organoid models: the future companions of personalized drug development. Biofabrication. 2024;16(3); DOI:10.1088/1758-5090/AD3E30.
- Xiao Y, Li Y, Jing X, Weng L, Liu X, Liu Q, Chen K. Organoid models in oncology: advancing precision cancer therapy and vaccine development. Cancer Biol Med. 2025;22(8):903–27; DOI:10.20892/J. ISSN.2095-3941.2025.0127.
- Xin-Yi J, Yan-Ran W, Pin-Ru D, Shi-Yi Q, Hai-Tao J. Organoids in cancer therapies: a comprehensive review. Front Bioeng Biotechnol. 2025;13: 1607488; DOI:10.3389/FBIOE.2025.1607488.
- Alnasser SM. From gut to liver: organoids as platforms for next-generation toxicology assessment vehicles for xenobiotics. Stem Cell Res Ther. 2025;16(1):150 DOI:10.1186/S13287-025-04264-Y.
- Astashkina A, Grainger DW. Critical analysis of 3-D organoid in vitro cell culture models for high-throughput drug candidate toxicity assessments. Adv Drug Deliv Rev. 2014;69-70:1-18; DOI:10.1016/J. ADDR.2014.02.008.
- Zhou L, Huang J, Li C, Gu Q, Li G, Li ZA, Xu J, Zhou J, Tuan RS. Organoids and organs-on-chips: recent advances, applications in drug development, and regulatory challenges. Med. 2025;6(4):100667; DOI:10.1016/J.MEDJ.2025.100667.
- Presley A, Samsa LA, Dubljević V. Media portrayal of ethical and social issues in brain organoid research. Philos Ethics Humanit Med. 2022;17(1):8; DOI:10.1186/S13010-022-00119-Z.
- de Jongh D, Massey EK; VANGUARD consortium; Bunnik EM. Organoids: a systematic review of ethical issues. Stem Cell Res Ther. 2022;13(1):337; DOI:10.1186/S13287-022-02950-9.
- Lavazza A, Chinaia AA. Human brain organoids and their ethical issues : navigating the moral and social challenges between hype and underestimation. EMBO Rep. 2024;25:13-6; DOI:10.1038/S44319-023-00007-3.
- Ding L, Xiao Z, Gong X, Peng Y. Knowledge graphs of ethical concerns of cerebral organoids. Cell Prolif. 2022;55(8):e13239; DOI:10.1111/CPR.13239.
- Kataoka M, Gyngell C, Savulescu J, Sawai T. The ethics of human brain organoid transplantation in animals. Neuroethics. 2023;16(3):27; DOI:10.1007/S12152-023-09532-3.
- Lavazza A, Reichlin M. Human Brain Organoids: Why there can be moral concerns if they grow up in the lab and are transplanted or destroyed. Camb Q Healthc Ethics. 2023;32(4):582-96; DOI:10.1017/S096318012300021X.
- Lewis J, Holm S. Organoid biobanking, autonomy and the limits of consent. Bioethics. 2022;36(7):742-56; DOI:10.1111/BIOE.13047.
- de Groot H, van Daal M, Hofland RW, Bronsveld I, Jongsma KR, Ten Ham RMT. The ethics and economics of organoid commercialization: potential donors’ perspectives. BMC Med Ethics. 2025;26(1):109; DOI:10.1186/S12910-025-01269-3.
- Hartung T, Morales Pantoja IE, Smirnova L. Brain organoids and organoid intelligence from ethical, legal, and social points of view. Front Artif Intell. 2024;6:1307613; DOI:10.3389/FRAI.2023.1307613.
- Bassil K. The end of ‘mini-brains’! Responsible communication of brain organoid research. Mol Psychol. 2024;2:13; DOI:10.12688/MOLPSYCHOL.17534.2.
DOI: https://doi.org/10.2478/acb-2026-0001 | Journal eISSN: 2544-3577
Language: English
Page range: 1 - 10
Submitted on: Dec 17, 2025
Accepted on: Feb 3, 2026
Published on: May 18, 2026
Published by: Foundation for Cell Biology and Molecular Biology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2026 Adrian Muzyka, Julia Rydzek, Aleksandra Pszczoła, Łucja Borkowska, Natalia Diakowska, Wojciech Grodzki, Julia Raś, Bernard Sartys, Martyna Ochman-Milarska, Marta Zawadzka, published by Foundation for Cell Biology and Molecular Biology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.